Ductal carcinoma in situ.
作者信息
Venniyoor Ajit
出版信息
Aust Fam Physician. 2006 May;35(5):278-9; author reply 279.
PMID:16708448
Abstract
摘要
相似文献
1
Ductal carcinoma in situ.导管原位癌
Aust Fam Physician. 2006 May;35(5):278-9; author reply 279.
2
[Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?].[低剂量他莫昔芬对原位乳腺癌是否为一种有效疗法？]
Vopr Onkol. 2011;57(5):601-3.
3
Designer estrogens: breast cancer benefit, remaining questions.设计雌激素：对乳腺癌有益，仍存疑问。
Health News. 1999 Jul 25;5(9):6.
4
[Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].[放疗与他莫昔芬有助于乳腺癌原位导管癌的保乳治疗]
Strahlenther Onkol. 1999 Dec;175(12):620-1.
5
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.国家综合癌症网络中随机临床试验结果对原位导管癌乳房手术后他莫昔芬使用情况的影响。
J Clin Oncol. 2007 Aug 1;25(22):3251-8. doi: 10.1200/JCO.2006.10.2699. Epub 2007 Jun 18.
6
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.完全切除原位导管癌的女性患者的放疗与他莫昔芬治疗
Lancet. 2003 Oct 4;362(9390):1154; author reply 1155-6. doi: 10.1016/S0140-6736(03)14474-1.
7
Tamoxifen in ductal carcinoma in situ.他莫昔芬用于导管原位癌
Semin Oncol. 2006 Dec;33(6):647-9. doi: 10.1053/j.seminoncol.2006.08.019.
8
Tamoxifen in premalignant and pre-invasive breast cancer.
Eur J Cancer Prev. 1993 Nov;2 Suppl 3:147-51.
9
Endocrine treatment for ductal carcinoma in situ: balancing risks and benefits.导管原位癌的内分泌治疗：权衡风险与获益
Lancet. 2016 Feb 27;387(10021):819-21. doi: 10.1016/S0140-6736(15)01219-2. Epub 2015 Dec 11.
10
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.完全切除原位导管癌的女性患者的放射治疗与他莫昔芬治疗
Lancet. 2003 Oct 4;362(9390):1155; author reply 1155-6. doi: 10.1016/s0140-6736(03)14477-7.
Zotero 插件